(EL) Estee Lauder Companies - NYSE
Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NYSE (USA) | Market Cap: 32.446m USD | Total Return: 22% in 12m
Avg Turnover: 322M
EPS Trend: -40.1%
Qual. Beats: 1
Rev. Trend: -82.1%
Qual. Beats: 0
Warnings
High Debt/EBITDA (6.1) with thin interest coverage (1.4)
Choppy
Tailwinds
No distinct edge detected
The Estée Lauder Companies Inc. (EL) is a global manufacturer and marketer of prestige skin care, makeup, fragrance, and hair care products. Founded in 1946 and headquartered in New York, the company maintains a diverse brand portfolio ranging from entry-level prestige like Clinique and The Ordinary to ultra-luxury labels such as La Mer and Tom Ford.
The company operates within the Personal Care Products sub-industry, utilizing an omnichannel distribution strategy that includes department stores, specialty retailers, and travel retail. A significant portion of its business model relies on the travel retail segment, which captures consumer spending in airport duty-free shops and is highly sensitive to international tourism trends.
Investors can evaluate the companys historical performance and valuation metrics on ValueRay. Unlike mass-market competitors, Estée Lauder focuses exclusively on the premium beauty segment, where brand equity and high-margin formulations serve as primary competitive advantages.
- China consumer spending weakness pressures high-margin prestige skincare volume
- Global travel retail recovery pace dictates quarterly earnings and inventory levels
- Profit recovery plan targets operating margin expansion through supply chain optimization
- Prestige fragrance segment growth offsets declining makeup demand in North America
- High exposure to department store foot traffic creates structural revenue risk
| Net Income: -248.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.77 > 1.0 |
| NWC/Revenue: 10.68% < 20% (prev 13.88%; Δ -3.20% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.80b > Net Income -248.0m |
| Net Debt (8.16b) to EBITDA (1.34b): 6.08 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (365.4m) vs 12m ago 1.11% < -2% |
| Gross Margin: 73.37% > 18% (prev 73.85%; Δ -0.47% > 0.5%) |
| Asset Turnover: 75.03% > 50% (prev 74.35%; Δ 0.68% > 0%) |
| Interest Coverage Ratio: 1.37 > 6 (EBIT TTM 527.0m / Interest Expense TTM 385.0m) |
| A: 0.08 (Total Current Assets 7.50b - Total Current Liabilities 5.91b) / Total Assets 19.7b |
| B: 0.59 (Retained Earnings 11.6b / Total Assets 19.7b) |
| C: 0.03 (EBIT TTM 527.0m / Avg Total Assets 19.8b) |
| D: 0.25 (Book Value of Equity 3.99b / Total Liabilities 15.7b) |
| Altman-Z'' = 2.90 = A |
| DSRI: 0.97 (Receivables 1.75b/1.79b, Revenue 14.8b/14.8b) |
| GMI: 1.01 (GM 73.85% / 73.37%) |
| AQI: 0.96 (AQ_t 0.38 / AQ_t-1 0.40) |
| SGI: 1.00 (Revenue 14.8b / 14.8b) |
| TATA: -0.10 (NI -248.0m - CFO 1.80b) / TA 19.7b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of June 15, 2026, the stock is trading at USD 89.68 with a total of 2,389,734 shares traded.
Over the past week, the price has changed by +7.41%,
over one month by +11.38%,
over three months by +1.43% and
over the past year by +22.00%.
Estee Lauder Companies has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold EL.
- StrongBuy: 6
- Buy: 5
- Hold: 13
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 95.7 | 6.7% |
P/E Forward = 28.0899
P/S = 2.1874
P/B = 7.9753
P/EG = 1.4246
Revenue TTM = 14.8b USD
EBIT TTM = 527.0m USD
EBITDA TTM = 1.34b USD
Long Term Debt = 6.81b USD (from longTermDebt, last quarter)
Short Term Debt = 903.0m USD (from shortTermDebt, last quarter)
Debt = 11.3b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.99b
Net Debt = 8.16b USD (calculated: Debt 11.3b - CCE 3.13b)
Enterprise Value = 40.6b USD (32.4b + Debt 11.3b - CCE 3.13b)
Interest Coverage Ratio = 1.37 (Ebit TTM 527.0m / Interest Expense TTM 385.0m)
EV/FCF = 31.60x (Enterprise Value 40.6b / FCF TTM 1.28b)
FCF Yield = 3.16% (FCF TTM 1.28b / Enterprise Value 40.6b)
FCF Margin = 8.66% (FCF TTM 1.28b / Revenue TTM 14.8b)
Net Margin = -1.67% (Net Income TTM -248.0m / Revenue TTM 14.8b)
Gross Margin = 73.37% ((Revenue TTM 14.8b - Cost of Revenue TTM 3.95b) / Revenue TTM)
Gross Margin QoQ = 71.04% (prev 76.55%)
Tobins Q-Ratio = 2.07 (Enterprise Value 40.6b / Total Assets 19.7b)
Interest Expense / Debt = 3.41% (Interest Expense 385.0m / Debt 11.3b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 416.3m (EBIT 527.0m * (1 - 21.00%))
Current Ratio = 1.27 (Total Current Assets 7.50b / Total Current Liabilities 5.91b)
Debt / Equity = 2.83 (Debt 11.3b / totalStockholderEquity, last quarter 3.99b)
Debt / EBITDA = 6.08 (Net Debt 8.16b / EBITDA 1.34b)
Debt / FCF = 6.35 (Net Debt 8.16b / FCF TTM 1.28b)
Total Stockholder Equity = 3.94b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.25% (Net Income -248.0m / Total Assets 19.7b)
RoE = -6.29% (Net Income TTM -248.0m / Total Stockholder Equity 3.94b)
RoCE = 4.90% (EBIT 527.0m / Capital Employed (Equity 3.94b + L.T.Debt 6.81b))
RoIC = 2.99% (NOPAT 416.3m / Invested Capital 13.9b)
WACC = 8.43% (E(32.4b)/V(43.7b) * Re(10.43%) + D(11.3b)/V(43.7b) * Rd(3.41%) * (1-Tc(0.21)))
Discount Rate = 10.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 67.42 | Cagr: 0.66%
[DCF] Terminal Value 77.70% ; FCFF base≈1.15b ; Y1≈1.32b ; Y5≈1.94b
[DCF] Fair Price = 83.38 (EV 28.8b - Net Debt 8.16b = Equity 20.6b / Shares 247.3m; r=8.43% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -40.12 | EPS CAGR: -10.11% | SUE: 1.48 | # QB: 1
Revenue Correlation: -82.11 | Revenue CAGR: -2.92% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-09-30): EPS=0.47 | Chg30d=-3.40% | Revisions=-20% | Analysts=16
EPS current Year (2026-06-30): EPS=2.42 | Chg30d=+1.55% | Revisions=+85% | GrowthEPS=+60.2% | GrowthRev=+4.5%
EPS next Year (2027-06-30): EPS=3.19 | Chg30d=+1.17% | Revisions=+78% | GrowthEPS=+31.7% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +85%